These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29019797)

  • 1. The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome.
    Antebi B; Mohammadipoor A; Batchinsky AI; Cancio LC
    J Trauma Acute Care Surg; 2018 Jan; 84(1):183-191. PubMed ID: 29019797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell therapy for acute respiratory distress syndrome: a promising future?
    Horie S; Masterson C; Devaney J; Laffey JG
    Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models.
    Huang Z; Liu H; Zhang X; Wen G; Zhu C; Zhao Y; Niu W; Qin Y; Chen H; Bai C; Liu G
    Int Immunopharmacol; 2018 Oct; 63():26-34. PubMed ID: 30064040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based therapies for the acute respiratory distress syndrome.
    Maron-Gutierrez T; Laffey JG; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):122-31. PubMed ID: 24300620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review.
    McIntyre LA; Moher D; Fergusson DA; Sullivan KJ; Mei SH; Lalu M; Marshall J; Mcleod M; Griffin G; Grimshaw J; Turgeon A; Avey MT; Rudnicki MA; Jazi M; Fishman J; Stewart DJ;
    PLoS One; 2016; 11(1):e0147170. PubMed ID: 26821255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cell therapies: potential and pitfalls for ARDS.
    Masterson C; Jerkic M; Curley GF; Laffey JG
    Minerva Anestesiol; 2015 Feb; 81(2):179-94. PubMed ID: 24492665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome.
    Han J; Liu Y; Liu H; Li Y
    Stem Cell Res Ther; 2019 Dec; 10(1):386. PubMed ID: 31843004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome.
    Li J; Huang S; Wu Y; Gu C; Gao D; Feng C; Wu X; Fu X
    Int Wound J; 2014 Apr; 11(2):114-21. PubMed ID: 24373614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome.
    Wang YY; Li XZ; Wang LB
    Stem Cell Res Ther; 2013 May; 4(3):45. PubMed ID: 23673003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress of mesenchymal stem cells in the treatment of ALI].
    Zhou H; Liu M; Lyu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Nov; 29(11):1039-1042. PubMed ID: 29151424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in mesenchymal stem cell-based therapy for acute lung injury.
    Liang J; Dai W; Xue S; Wu F; Cui E; Pan R
    Cell Tissue Bank; 2024 Jun; 25(2):677-684. PubMed ID: 38466563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome.
    Matthay MA
    Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S54-7. PubMed ID: 25830837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS.
    Huppert LA; Liu KD; Matthay MA
    Transfusion; 2019 Feb; 59(S1):869-875. PubMed ID: 30383290
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesenchymal Stem Cell Therapy for ALI/ARDS: Therapeutic Potential and Challenges.
    Wang Z; Yu T; Hou Y; Zhou W; Ding Y; Nie H
    Curr Pharm Des; 2022; 28(27):2234-2240. PubMed ID: 35796453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential and mechanisms of action of mesenchymal stromal cells for Acute Respiratory Distress Syndrome.
    Curley GF; Scott JA; Laffey JG
    Curr Stem Cell Res Ther; 2014; 9(4):319-29. PubMed ID: 24588087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis.
    Walter J; Ware LB; Matthay MA
    Lancet Respir Med; 2014 Dec; 2(12):1016-26. PubMed ID: 25465643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells: a promising therapy for the acute respiratory distress syndrome.
    Cárdenes N; Cáceres E; Romagnoli M; Rojas M
    Respiration; 2013; 85(4):267-78. PubMed ID: 23428562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Orphan Receptor Tyrosine Kinase ROR2 Facilitates MSCs to Repair Lung Injury in ARDS Animal Model.
    Cai SX; Liu AR; Chen S; He HL; Chen QH; Xu JY; Pan C; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB
    Cell Transplant; 2016; 25(8):1561-74. PubMed ID: 26531175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives.
    Fernández-Francos S; Eiro N; González-Galiano N; Vizoso FJ
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.
    Liu A; Zhang X; He H; Zhou L; Naito Y; Sugita S; Lee JW
    Expert Opin Biol Ther; 2020 Feb; 20(2):125-140. PubMed ID: 31701782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.